Catheter Precision Inc. (AMEX: VTAK): This Is The Year For Success Over The Next Few Months

NOVA

In the last trading session, 8.51 million Catheter Precision Inc. (AMEX:VTAK) shares changed hands as the company’s beta touched -0.33. With the company’s per share price at $0.92 changed hands at $0.01 or 0.55% during last session, the market valuation stood at $2.56M. VTAK’s last price was a discount, traded about -813.04% off its 52-week high of $8.40. The share price had its 52-week low at $0.31, which suggests the last value was 66.3% up since then. When we look at Catheter Precision Inc.’s average trading volume, we note the 10-day average is 19.94 million shares, with the 3-month average coming to 3.14 million.

Catheter Precision Inc. (AMEX:VTAK) trade information

Instantly VTAK was in green as seen at the end of in last trading. With action 161.43%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -77.37%, with the 5-day performance at 161.43% in the green. However, in the 30-day time frame, Catheter Precision Inc. (AMEX:VTAK) is 103.33% up. Looking at the short shares, we see there were 46547.0 shares sold at short interest cover period of 0.1 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Catheter Precision Inc. (VTAK) estimates and forecasts

Data shows that the Catheter Precision Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -79.44% over the past 6 months, a 92.80% in annual growth rate that is considerably higher than the industry average of 13.70%. Year-over-year growth is forecast to reach 621.70% up from the last financial year.

Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 1.06M. 1 analysts are of the opinion that Catheter Precision Inc.’s revenue for the current quarter will be 1.66M. The company’s revenue for the corresponding quarters a year ago was 133k and 128k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 697.00%. The estimates for the next quarter sales put growth at 1,196.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 66.41%.

VTAK Dividends

Catheter Precision Inc. is expected to release its next quarterly earnings report in November.

Catheter Precision Inc. (AMEX:VTAK)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 16.78% of Catheter Precision Inc. shares while 2.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.04%.